COMPANY
Splash Pharmaceuticals
Timeline
- Trial start Phase 1: Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03078400 | Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer | Phase 1 | Unknown status (ClinicalTrials.gov) | Mar 10, 2017 | Jan 31, 2020 (actual) |